Ardena’s approach is to combine production of drug product and patient kits at a single site.
This highly efficient strategy has a number of advantages. It allows us to supply combined product and patient kits in a single shipment, ensuring trial sites have the supplies they need to start generating high quality data as soon as possible.
Our approach also means our drug product and patient kit teams can work work together in an efficient and reactive manner. In short, Ardena is unique in the sector by offering both CDMO and bioanalytical services in combination with the production and supply of sample kits.
Our clinical logistics capabilities include:
- Team of five trained in IATA packing instructions
- Secondary packaging for drug products
- In house label printing and labelling in dedicated rooms
- Warehouse storage for primary and secondary packaged materials
- Temperature controlled storage areas, including a 2-8°C storage area
- QP release services